A new milestone in non-pharmaceutical treatments for depression | Nick Davis

Last week’s announcement that a UK company won US approval for device-based treatment of depression is excellent news for taking academic findings into a clinical settingMood disorders such as depression are devastating to sufferers, and hugely costly to treat. The most severe form of depression, often called clinical depression or major depressive disorder (MDD), increases the person’s likelihood of suicide and contributes significantly to a person’s disability-adjusted life years (DALYs)